UBS Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

UBS Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-80,000	Closed	-$3.75M	–	8623
2020 Q1	$3.75M	Buy	+80,000	New	+$5.13M	﹤0.01%	2174
2019 Q4	–	Sell	-5,000	Closed	-$261K	–	8619
2019 Q3	$261K	Buy	+5,000	New	+$266K	﹤0.01%	5044

UBS Group's MYOK Position: Q4 2020 in Review

UBS Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 2,660 shares — an estimated $363K sold.

UBS Group first reported a position in MYOK in Q2 2016 and held it in 16 quarters. The position peaked at $3.52M in Q3 2017. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

UBS Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
UBS Group sold 2,660 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $363K.
UBS Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2016 and held it in 16 quarters.
UBS Group's MyoKardia, Inc. Common Stock position peaked at $3.52M in Q3 2017.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.